Cargando…

Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality

BACKGROUND: Whether achieving sustained virological response (SVR) in patients with hepatitis C attains complete elimination of hepatitis C virus (HCV) is unknown, because occult HCV infection (OCI), defined as the detection of HCV-RNA in hepatocytes or peripheral blood mononuclear cells (PBMC) in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yijin, Rao, Huiying, Chi, Xiumei, Li, Boan, Liu, Hongyang, Wu, Liyuan, Zhang, Hao, Liu, Shuhong, Zhou, Gaungde, Li, Na, Niu, Junqi, Wei, Lai, Zhao, Jingmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711338/ https://www.ncbi.nlm.nih.gov/pubmed/31345785 http://dx.doi.org/10.1016/j.ebiom.2019.07.043

Ejemplares similares

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR
por: Chadha, Nikita, et al.
Publicado: (2022)

Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections
por: Manickam, Cordelia, et al.
Publicado: (2014)

Poor Outcomes of Acute Hepatitis E in Patients With Cirrhotic Liver Diseases Regardless of Etiology
por: Wang, Yijin, et al.
Publicado: (2020)

Molecular Virology of Hepatitis C Virus (HCV): 2006 Update
por: Brass, Volker, et al.
Publicado: (2006)

The Relationship between Virological Characteristics of Hepatitis C Virus (HCV) and Reactivity to the Regional Specific Proteins of HCV(*)
por: Yoon, Seung Kew, et al.
Publicado: (2000)

Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
por: Mihai, Florin, et al.
Publicado: (2020)

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
por: Smit, Colette, et al.
Publicado: (2015)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

Random effect model for identifying related factors to virological response in HCV patients
por: Zayeri, Farid, et al.
Publicado: (2013)

301. Risk of Virologic Failure with Antiretroviral Switches in HIV/HCV Co-infections
por: Mosquera, Diana M, et al.
Publicado: (2019)

HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
por: Roggenbach, Imme, et al.
Publicado: (2021)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

Low-level residual viremia and risk of virological failure
por: Cologni, G, et al.
Publicado: (2010)

Virological and histological evaluation of intestinal samples in COVID-19 patients
por: Cuicchi, Dajana, et al.
Publicado: (2022)

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
por: Welzel, Tania M, et al.
Publicado: (2016)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2013)

Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response
por: Khattab, Mahmoud A., et al.
Publicado: (2022)

Erratum: Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
Publicado: (2016)

Histological changes in HCV antibody–positive, HCV RNA–negative subjects suggest persistent virus infection
por: Hoare, Matthew, et al.
Publicado: (2008)

The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C.
por: Lee, Y. S., et al.
Publicado: (2001)

Silent damage? Occult HCV replication and histological disease may occur following apparent HCV clearance
por: Manickam, Cordelia, et al.
Publicado: (2019)

Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in China
por: Xu, Hongqin, et al.
Publicado: (2015)

Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease
por: Chevaliez, Stéphane, et al.
Publicado: (2006)

Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials
por: Loftfield, Erikka, et al.
Publicado: (2016)

2224. Receipt and Virologic Outcomes of HCV Direct-Acting Antivirals by Alcohol Use and HIV Status
por: Cartwright, Emily J, et al.
Publicado: (2018)

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
por: Hamdane, Nourdine, et al.
Publicado: (2019)

Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC
por: Gao, Xiuzhu, et al.
Publicado: (2020)

HCV Genomic RNA Activates the NLRP3 Inflammasome in Human Myeloid Cells
por: Chen, Wei, et al.
Publicado: (2014)

Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression
por: Liu, Yuan, et al.
Publicado: (2016)

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
por: Arcaini, Luca, et al.
Publicado: (2012)

Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV
por: Odolini, Silvia, et al.
Publicado: (2014)

Host genetic variations are associated with virological response to interferon therapy of chronic HCV in Han Chinese patients
por: Chen, Hongbo, et al.
Publicado: (2014)

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis
por: Radhakrishnan, Kavita, et al.
Publicado: (2019)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
por: Orr, Cody, et al.
Publicado: (2020)

Frequency and predictive factors of minimal hepatic encephalopathy before and after sustained virological response in HCV cirrhosis
por: Piedade, Juliana, et al.
Publicado: (2022)

Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir
por: Abi-Saleh, Simon P, et al.
Publicado: (2023)

Expression of selected genes in liver biopsy specimens in relation to early virological response in patients with chronic hepatitis C with HCV mono- and HIV/HCV co-infection
por: Jabłonowska, Elżbieta, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ga0lct3ngilb8g0vdfm750a9ct